Stay updated on Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.

Latest updates to the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page
- Check5 days agoChange DetectedThe page history lists past versions of the study record with status updates such as Study Status and Recruitment Status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a government-operating status notice and a new version tag (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference13%

- Check41 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

- Check55 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; the Back to Top element was removed, with no other substantive content changes.SummaryDifference0.8%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.8%

- Check69 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference8%

Stay in the know with updates to Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.